%0 Journal Article
%T Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes
%A Christopher Strauch
%A David R. Sell
%A John M. Lachin
%A Patricia A. Cleary
%A Saul Genuth
%A The DCCT/EDIC Research Group
%A Vincent M. Monnier
%A Wanjie Sun
%A Xiaoyu Gao
%J Archive of "Cardiovascular Diabetology".
%D 2016
%R 10.1186/s12933-016-0343-3
%X Skin collagen Long Wavelength Fluorescence (LWF) is widely used as a surrogate marker for accumulation of advanced glycation end-products. Here we determined the relationship of LWF with glycemia, skin fluorescence, and the progression of complications during EDIC in 216 participants from the DCCT
%K Glycation
%K Skin autofluorescence
%K HbA1c
%K Retinopathy
%K Nephropathy
%K Neuropathy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750185/